Pharmafile Logo

Mastering Outcome vs. Process Control in Remote Work – Building Company Culture Virtually

Struggling to manage your remote pharma teams effectively? Discover the power of outcome control. Learn how trusting your team to achieve results, their way, can lead to greater productivity and a more positive work culture. Stop micromanaging, start empowering!

In the seventh video of our series on creating company culture in a virtual environment, explore the essential leadership shift from process control to outcome control in remote work settings. Learn how this approach can enhance productivity and employee empowerment.

7. Learn the Difference Between Outcome Control vs. Process Control
In the remote work era, the traditional concerns about productivity have shifted as leaders gain more experience and confidence in their teams. This is why it’s crucial for leaders to focus on outcome control rather than process control. With the blending of work life and home life, especially evident in 2020, employees may need to juggle home-schooling children, sharing office spaces with partners, and more. By prioritizing outcomes over the specifics of day-to-day processes, leaders can trust their teams to achieve their goals in the way that best suits their unique circumstances. This shift not only empowers employees but also streamlines productivity, making the transition to remote work more sustainable and effective for everyone involved.

For deeper insights and to learn from our experiences, visit our blog: https://www.impetusdigital.com/2020/11/03/top-10-tips-for-creating-company-culture/

Enhance your virtual meeting strategies with Impetus Digital:

Stay connected for more tips on remote work and trending Pharma Topics:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Beat inflation with virtual meetings and programs

At the time of writing, the average inflation rate worldwide sits at 7.4%, the highest it’s been for decades. Here in Canada, the inflation rate is not forecasted to come back down...

Engaging KOLs & Gaining Insights in Pharma’s New Normal

Kaitlin Anstett, Senior Medical Advisor at Theratechnologies, shares her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important...

There’s No Going Back: How COVID-19 will Change Pharma Forever

Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...

Powering Rapid Cognitive Analysis with AI

Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.

KOL Ambassador Program & Podcast Creation: A Customer Story

Leveraging Impetus Digital’s best-in-class synchronous (real-time) and asynchronous (over-time, anytime) tools, our client facilitated a virtual ambassador program with three oncologist key opinion leaders (KOLs) from South Korea.The client’s main objectives...

Importance of Emotional Intelligence in Pharma and Medical Affairs

Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, explores a number of interesting topics related to Medical Affairs. Among many other things, she discusses the importance of emotional...

Virtual product launch planning: the ultimate playbook

We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...